KEOCYT

keocyt-logo

Keocyt SA develops pharmaceutical products. It offers drugs for epilepsy and cancer treatment. Its product line includes estramustin, a solution used in the treatment of prostate cancer; streptozocin, a solution used in the treatment of neuroendocrine tumors; and phenytoin and fosphenytoin used in the treatment of epilepsy.

#SimilarOrganizations #Website #More

KEOCYT

Industry:
Pharmaceutical

Founded:
2006-01-01

Address:
Malakoff, Ile-de-France, France

Country:
France

Website Url:
http://www.keocyt.com

Status:
Active

Contact:
+33 1 42 31 07 10

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Salesforce SPF DocuSign Diligent


Similar Organizations

not_available_image

EuPharmed

EuPharmed is develops and markets pharmaceutical products.

Official Site Inspections

http://www.keocyt.com

  • Host name: 193.25.192.20.es.colt.net
  • IP address: 193.25.192.20
  • Location: Barcelona Spain
  • Latitude: 41.3891
  • Longitude: 2.1611
  • Timezone: Europe/Madrid
  • Postal: 08015

Loading ...

More informations about "Keocyt"

Keocyt - Products, Competitors, Financials, Employees, โ€ฆ

Keocyt is a privately owned company operating in Paris, France. Founded in 2007 by Jean-Francois Auffret and Christophe Pasik, Keocyt as specialty pharma company, focusing on โ€ฆSee details»

Keocyt Company Profile 2024: Valuation, Investors, Acquisition

Keocyt General Information Description. Developer of specialty pharmaceutical products intended to focus on oncology and neurology. The company mainly offers medicines that are used in โ€ฆSee details»

Keocyt SAS - Company Profile and News - Bloomberg Markets

Company profile page for Keocyt SAS including stock price, company news, executives, board members, and contact informationSee details»

KEOCYT Information - RocketReach

The NAICS codes for KEOCYT are [32, 32541, 325, 3254]. What is the SIC code for KEOCYT? The SIC codes for KEOCYT are [283, 28]. Top KEOCYT Employees Christophe Pasik Owner โ€ฆSee details»

Keocyt SA Company Profile, Financial and Strategic SWOT Analysis ...

Keocyt SA develops pharmaceutical products. The company offers drugs for epilepsy and cancer treatment. Its product line includes estramustin, a solution used in the treatment of prostate โ€ฆSee details»

RIEMSER Pharma GmbH Announces Takeover of Keocyt, a French ...

May 12, 2014 Keocyt is a privately owned company operating in Paris, France. Founded in 2007 by Jean-Francois Auffret and Christophe Pasik , Keocyt as specialty pharma company, โ€ฆSee details»

Keocyt devient ESTEVE France - MyPharma Editions

Jun 7, 2022 En janvier 2022, la filiale française du groupe pharmaceutique ESTEVE, basé à Barcelone, a changé de nom et devient ESTEVE France. En 2 ans, avec lโ€™acquisition du โ€ฆSee details»

Riemser Pharma acquires French drugmaker Keocyt

May 12, 2014 Keocyt brings to market pharmaceutical products that are applied in the treatment of rare diseases, especially in cancer therapy and neurology. The Paris based company was โ€ฆSee details»

Keocyt SASU: Drug pipelines, Patents, Clinical trials - Synapse

Jul 9, 2023 Explore Keocyt SASU with its drug pipeline, therapeutic area, technology platform, 1 clinical trial.See details»

Organization | Keocyt

Organization Overview. First Clinical Trial. 2017 NCT03240731. First Marketed Drug. None First NDA Approval. None Last Known Activity. 2017 Timeline < Back; View all... NOW. Now; Active โ€ฆSee details»

Riemser Pharma va acquérir le français Keocyt

May 21, 2014 La société allemande Riemser Pharma, fabricant de produits pharmaceutiques de spécialité, a annoncé aujourd'hui l'acquisition de la société pharmaceutique française Keocyt โ€ฆSee details»

Keocyt - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Keocyt develops pharmaceutical products. ... Start Free Trial . Chrome ExtensionSee details»

ESTEVE Keocyt - Forbidden DevelopmentAid

ESTEVE is a global pharmaceutical company based in Barcelona, Spain, dedicated to improving people's lives through innovation. Since its inception in 1929, it has focused on helping โ€ฆSee details»

RIEMSER Pharma acquires Keocyt - 2014-05-12 - Crunchbase

RIEMSER Pharma acquires Keocyt on 2014-05-12 for an undisclosed amount. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... Keocyt โ€ฆSee details»

Riemser übernimmt Pharmaunternehmen Keocyt | Das โ€ฆ

May 15, 2014 Keocyt vermarktet pharmazeutische Produkte, die für die Behandlung seltener Erkrankungen insbesondere in der Krebstherapie und in der Neurologie eingesetzt werden. โ€ฆSee details»

Riemser Pharma takes over Keocyt - Manufacturing Chemist

May 12, 2014 Keocyt brings to market pharmaceutical products that are applied in the treatment of rare diseases, especially in cancer therapy and neurology. The Paris-based company was โ€ฆSee details»

Keocyt devient ESTEVE France - Industrie Mag

Keocyt, filiale française détenue par Riemser depuis 2014 et rebaptisée aujourdโ€™hui ESTEVE France, est présente dans les domaines de la médecine neurologique et en cancérologie avec โ€ฆSee details»

Why workplace communication is key to success | Hays US

It may sound like a subtle difference but focus on actively listening rather than simply hearing someone. Use visual cues and body language to show that you are listening. This small โ€ฆSee details»

Private Foundation Vs. Public Charity: Key Differences Explained

Mar 27, 2025 What makes an organization charitable? Many people might point to its mission, its impact on the community, or how much it gives back. But for those working behind the scenes โ€ฆSee details»

Digital Transformation Examples Worth Copying | VisualSP

1 day ago They align with the organizationโ€™s business strategy and operation model. Leaders who focus their digital transformation efforts on empowering employees create lasting change. โ€ฆSee details»

linkstock.net © 2022. All rights reserved